Market Scenario
The global apheresis market size is projected to grow at a 8.90 % CAGR during the forecast period (2023-2030). The apheresis market is witnessing significant growth globally, driven by advancements in technology, increasing prevalence of chronic diseases, and rising demand for blood components and plasma-derived therapies. Apheresis, a medical procedure involving the separation and extraction of blood components such as plasma, platelets, or white blood cells, plays a crucial role in treating various conditions including autoimmune disorders, neurological diseases, and hematologic malignancies. The market is characterized by a growing number of applications, including therapeutic apheresis for treating diseases like leukemia and myasthenia gravis, as well as the collection of blood components for transfusion and research purposes.
Technological innovations and the introduction of automated apheresis systems are driving market expansion, offering improved efficiency, reduced procedure times, and enhanced safety for patients. Moreover, the increasing demand for personalized medicine and targeted therapies is expected to fuel further market growth as apheresis procedures enable the precise extraction and manipulation of specific blood components tailored to individual patient needs. With a rising emphasis on blood safety and the growing adoption of apheresis procedures in both developed and developing regions, the global apheresis market is projected to continue its upward trajectory in the coming years, presenting lucrative opportunities for market players and healthcare providers alike.
The Apheresis market is witnessing significant growth, driven by the increasing adoption of advanced therapeutic procedures such as selective plasma filtration and plasma pheresis. Selective plasma filtration is a cutting-edge technique that allows for the precise removal of targeted substances from the blood, offering a tailored approach to treating various medical conditions. This process involves separating plasma from blood cells, passing it through a specialized filter to remove specific components, and then returning the purified plasma back to the patient's circulation. By selectively removing harmful substances while preserving essential blood components, selective plasma filtration has emerged as a promising tool in the treatment of autoimmune disorders, neurological diseases, and certain cancers.
Competitive Dashboard
The Major Apheresis Players operating the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.
Drivers and Constraints Impacting the Market
With the growing prevalence of chronic renal diseases and blood-related diseases, the global apheresis market is considered to stimulate during the estimated period. Increasing complex surgical procedures, rising demand for different component of blood, and growing number of accidents across the globe are considered to augment the market growth in the coming years. Demand for platelets and plasma has also increased which is further impacting the global market positively. Moreover, with continuous advancement in technology and growing need for advanced and automated devices, the market is likely to foster.
On the flip side, high cost of procedures and lack of skilled professionals are some of the major factors considered to impede the market growth in the coming years.
Global Apheresis Market: Segmental Analysis
The global apheresis market has been segmented on the basis of product, procedure, methods, application, end-users, and region.
By mode of product, global apheresis market has been segmented into devices and disposables. The devices segment has been further sub-segmented into platelets separators, plasma separators, and others.
By mode of procedure, the global apheresis market has been segmented into leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and others.
By mode of methods, the global apheresis market has been segmented into filtration and centrifugation. Among these, centrifugation is further sub-segmented into intermittent flow centrifugation, continuous flow centrifugation, and others.
By mode of application, the global apheresis market has been segmented into oncological diseases, immunological diseases, hematological diseases, cardiovascular diseases, renal diseases, neurological diseases, and others.
By mode of end-users, the global apheresis market has been segmented into hospitals, blood banks, and others.
Regional Insights
Geographically, apheresis market span across regions namely, America, Europe, Asia Pacific, and Rest-of-the-World (RoW).
Among all the regions, America is considered to hold the largest position in the global market and is expected to maintain its dominance during the assessment period. The growth is attributed to the advancement in technology and growing opportunity for apheresis products coupled with the presence of a huge patient population suffering from chronic diseases.
Asia Pacific is considered to be the fastest growing region in the global market owing to the growing demand for blood components for patients. Moreover, rapid development in the healthcare industry along with growing expenditure on health care is considered to contribute to the growth of the global market.
Related Reports-
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian